Cargando…
Targeted α-Particle Radiation Therapy of HER1-Positive Disseminated Intraperitoneal Disease: An Investigation of the Human Anti-EGFR Monoclonal Antibody, Panitumumab
Identifying molecular targets and an appropriate targeting vehicle, i.e., monoclonal antibodies (mAb) and their various forms, for radioimmunotherapy (RIT) remains an active area of research. Panitumumab, a fully human and less immunogenic mAb that binds to the epidermal growth factor receptor (Erb1...
Autores principales: | Milenic, Diane E., Baidoo, Kwamena E., Kim, Young-Seung, Barkley, Rachel, Brechbiel, Martin W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Neoplasia Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5458064/ https://www.ncbi.nlm.nih.gov/pubmed/28577439 http://dx.doi.org/10.1016/j.tranon.2017.04.004 |
Ejemplares similares
-
Mechanisms of Cell Killing Response from Low Linear Energy Transfer (LET) Radiation Originating from (177)Lu Radioimmunotherapy Targeting Disseminated Intraperitoneal Tumor Xenografts
por: Yong, Kwon Joong, et al.
Publicado: (2016) -
In Vitro and In Vivo Analysis of Indocyanine
Green-Labeled Panitumumab for Optical Imaging—A Cautionary
Tale
por: Zhou, Yang, et al.
Publicado: (2014) -
HER1-Targeted (86)Y-Panitumumab Possesses Superior Targeting Characteristics than (86)Y-Cetuximab for PET Imaging of Human Malignant Mesothelioma Tumors Xenografts
por: Nayak, Tapan K., et al.
Publicado: (2011) -
Pre-Clinical Assessment of (177)Lu-Labeled Trastuzumab Targeting HER2 for Treatment and Management of Cancer Patients with Disseminated Intraperitoneal Disease
por: Ray, Geoffrey L., et al.
Publicado: (2011) -
In vitro and in vivo pre-clinical analysis of a F(ab')(2 )fragment of panitumumab for molecular imaging and therapy of HER1-positive cancers
por: Wong, Karen J, et al.
Publicado: (2011)